Heerspink, H., Noronha, I., Górriz, J., Lim, S., Kotwal, S., Kirsztajn, G., . . . Mottl, A. (2026). Efficacy and Safety of Atrasentan in Patients with IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors Placebo-Controlled, Crossover Trial.
Citação norma ChicagoHeerspink, HJL, et al. Efficacy and Safety of Atrasentan in Patients With IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors Placebo-Controlled, Crossover Trial. 2026.
Citação norma MLAHeerspink, HJL, et al. Efficacy and Safety of Atrasentan in Patients With IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors Placebo-Controlled, Crossover Trial. 2026.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.